期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Potential efficacy and mechanism of medicinal plants on chronic kidney disease-associated vascular calcification:a review
1
作者 Han-Qing Zhang Shuang Wu +8 位作者 Xin Chen Ya-Xuan Fang Qiu-Mei Lan Zi-Jun Zhou Yan-Heng Qiao Jie Li yan-ru zhao Ming Pei Bo Yang 《Traditional Medicine Research》 2024年第9期21-31,共11页
Vascular calcification is a crucial risk factor that affects the incidence and mortality of cardiovascular disease in chronic kidney disease patients.Modern medicine relies on calcium-phosphorus binding agents,calcium... Vascular calcification is a crucial risk factor that affects the incidence and mortality of cardiovascular disease in chronic kidney disease patients.Modern medicine relies on calcium-phosphorus binding agents,calcium mimetics,active vitamin D,and hemodialysis to prevent and treat vascular calcification,however,their efficacy is unsatisfactory and adverse reactions often occur.Medical plant therapy can act as an integrative regulator in patients with chronic kidney disease-associated vascular calcification,which can significantly improve patients’symptoms,but its specific mechanism has not been fully elucidated yet.In this paper,we reviewed the domestic and international theoretical studies on the pathogenesis mechanism of chronic kidney disease-associated vascular calcification in recent years,summarized eight active ingredients of medicinal plants as well as four compound formulas for improving chronic kidney disease-associated vascular calcification,and explored the mechanism of action of herbal medicine,which will provide a new strategy for promoting the prevention and treatment of vascular calcification. 展开更多
关键词 chronic kidney disease chronic kidney disease-mineral and bone disorder(CKD-MBD) vascular calcification medicinal plants herbal monomers
下载PDF
Acute kidney injury:microRNAs and new therapeutic opportunities for natural products
2
作者 Ke Zhong Han-Qing Zhang +6 位作者 Ya-Xuan Fang Qiu-Mei Lan Zi-Jun Zhou yan-ru zhao Yan-Heng Qiao Jie Li Bo Yang 《Traditional Medicine Research》 2023年第11期1-13,共13页
In the past few decades,acute kidney injury(AKI),characterized by an abrupt decrease in kidney filtration rate,has become a public health issue affecting between 1%and 15%of the population,which causes high morbidity ... In the past few decades,acute kidney injury(AKI),characterized by an abrupt decrease in kidney filtration rate,has become a public health issue affecting between 1%and 15%of the population,which causes high morbidity and death.There is mounting evidence that miRNAs are noncoding single-stranded RNAs with a short length of about 20 nucleotides and have been highly conserved through evolution.Through targeting mRNAs,miRNA may mediate intercellular communication during AKI’s physiological and pathological processes.It is interesting to note that natural products can improve AKI by regulating miRNA expression,which might represent a potentially innovative therapeutic strategy.This review aims at providing an overview of the new data obtained on miRNAs in the treatment and diagnosis of AKI,summarizing studies on natural products improving AKI through regulating miRNAs’expression;in the same time,it will shed new light on AKI risk biomarkers and therapeutic intervention as well.We summarized the roles of miRNAs involved in AKI progression or protection against renal injury in 32 articles;we found five natural products can improve AKI by regulating miRNA expression,which will potentially provide a reference for clinical treatment.Natural products might represent a potentially innovative therapeutic strategy;in the same time,miRNAs will shed new light on AKI risk biomarkers and therapeutic intervention. 展开更多
关键词 MICRORNA acute kidney injury natural products BIOMARKER
下载PDF
自拟活血清肺方对慢性阻塞性肺疾病患者C反应蛋白水平及肺功能的影响 被引量:7
3
作者 王娜 赵艳茹 肖鹏云 《中国现代医学杂志》 CAS 北大核心 2021年第3期42-47,共6页
目的探讨自拟活血清肺方对慢性阻塞性肺疾病(COPD)患者C反应蛋白(CRP)水平及肺功能的影响。方法选取2017年6月—2018年7月于北京中医医院顺义医院呼吸科收治的91例COPD稳定期患者,采用随机数字表法分为研究组和对照组,常规治疗基础上研... 目的探讨自拟活血清肺方对慢性阻塞性肺疾病(COPD)患者C反应蛋白(CRP)水平及肺功能的影响。方法选取2017年6月—2018年7月于北京中医医院顺义医院呼吸科收治的91例COPD稳定期患者,采用随机数字表法分为研究组和对照组,常规治疗基础上研究组给予自拟活血清肺方和沙美特罗替卡松粉吸入剂治疗,常规治疗基础上对照组给予沙美特罗替卡松粉吸入剂治疗。比较两组患者治疗前后中医证候积分、综合疗效、肺功能、炎症因子水平及血液流变学指标,并进行安全性检测。结果研究组治疗后中医证候积分较对照组低(P<0.05),总有效率较对照组高(P<0.05)。研究组治疗后用力肺活量(FVC)、第一秒用力呼气容积(FEV1)、FEV1/FVC较对照组高(P<0.05)。研究组治疗前后FVC、FEV1、FEV1/FVC差值较对照组高(P<0.05)。研究组治疗后血清CRP、IL-6、IL-8及TNF-α水平较对照组低(P<0.05)。研究组治疗前后血清CRP、IL-6、IL-8及TNF-α差值较对照组高(P<0.05),研究组治疗后全血高切黏度、全血低切黏度、纤维蛋白原及血细胞比容较对照组低(P<0.05)。研究组治疗前后全血高切黏度、全血低切黏度、纤维蛋白原及血细胞比容差值较对照组高(P<0.05)。两组患者治疗前后心电图、血常规、肝肾功能、尿常规检查均无异常,且研究期间未出现明显不良反应。结论自拟活血清肺汤联合沙美特罗替卡松粉吸入剂可有效改善COPD患者体内炎症反应状态,提高肺功能且安全性较高,值得临床推广应用。 展开更多
关键词 肺疾病 慢性阻塞性 C反应蛋白质 呼吸功能试验
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部